RNS No 3611c
THERAPEUTIC ANTIBODIES INC
6th November 1998


Therapeutic Antibodies Inc 
(the "Company")
Special Shareholder Meeting approves increase in Share Capital

The directors of the Company announce that at the Special Shareholder Meeting
held at 8am today (Nashville time) shareholders approved the increase in the
Company's authorised share capital.  

This increase in the authorised capital was required in order to complete the
Company's refinancing, including the placing of 21,300,000 shares of common
stock, announced on 26 October 1998.  Dealings are expected to commence in the
shares issued pursuant to the refinancing and the placing on 9 November 1998.

Enquiries:

Dr Andrew Heath, Chief Executive Officer
Saul Komisar, Investor Relations Manager
Therapeutic Antibodies Inc
Nashville, USA  
00 1 615 327 1027

William Clutterbuck, Laura Frost
The Maitland Consultancy
0171 379 5151

END

ROMGLMGMKVMLRMM
Becket Invest (LSE:TAB)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024 Plus de graphiques de la Bourse Becket Invest
Becket Invest (LSE:TAB)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024 Plus de graphiques de la Bourse Becket Invest